Crescent Biopharma, Inc. · NASDAQ:CBIO

Bispham Barbara Harlin sold 620 Crescent Biopharma, Inc. shares (Form 4)

Traded Sep 16, 2026 · Filed Sep 18, 2026

On Sep 16, 2026, Bispham Barbara Harlin (See Remarks) sold 620 Crescent Biopharma, Inc. shares at US$17.90 for US$11,098 under a trading plan, leaving 18,710 shares. Filed Sep 18, 2026 (Form 4).

Sold
620 shares
Price
US$17.90
Value
US$11,098
Holding after
18,710 shares
Trading plan
Yes (Made under a plan set in advance)
Role
See Remarks

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 16, 2026Ordinary SharesSale620US$17.9018,710Direct

Source

View original at SEC

Related